BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang YT, Hsieh YY, Chen WM, Tung SY, Wei KL, Shen CH, Chang KC, Lu CK, Yen CW, Lu SN, Hung CH, Chang TS. Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan. BMC Gastroenterol 2021;21:259. [PMID: 34118889 DOI: 10.1186/s12876-021-01837-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Merli M, Rattotti S, Spina M, Re F, Motta M, Piazza F, Orsucci L, Ferreri AJM, Perbellini O, Dodero A, Vallisa D, Pulsoni A, Santoro A, Sacchi P, Zuccaro V, Chimienti E, Russo F, Visco C, Zignego AL, Marcheselli L, Passamonti F, Luminari S, Paulli M, Bruno R, Arcaini L. Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi. J Clin Oncol 2022;:JCO2200668. [PMID: 35714311 DOI: 10.1200/JCO.22.00668] [Reference Citation Analysis]
2 Shabbir AB, Liaqat M, Muhammad Atif H. Successful Eradication of Hepatitis C Virus with Sofosbuvir based Antiviral treatment results in improvement in quality of life in cirrhotic patients. PBMJ 2022. [DOI: 10.54393/pbmj.v5i4.385] [Reference Citation Analysis]
3 Mangrio GR, Maneengam A, Khalid Z, Jafar TH, Chanihoon GQ, Nassani R, Unar A. RP-HPLC Method Development, Validation, and Drug Repurposing of Sofosbuvir Pharmaceutical Dosage Form: A Multidimensional Study. Environ Res 2022;212:113282. [PMID: 35487258 DOI: 10.1016/j.envres.2022.113282] [Reference Citation Analysis]
4 Sofosbuvir/velpatasvir. Reactions Weekly 2021;1871:378-378. [DOI: 10.1007/s40278-021-01897-7] [Reference Citation Analysis]